The Potential Depigmenting Activity of Retinaldehyde

Background: Retinoids have been reported to exert depigmenting activity. Unlike most depigmenting agents that target tyrosinase, they are not phenolic agents and may act via different mechanisms. Objectives: We analysed the properties of retinaldehyde (RAL), a precursor of retinoic acid (RA), as a skin-lightening agent in various models. Methods: The viability and the depigmenting properties of RAL were assessed in murine melanocytes, in human reconstructed epidermis, and in mice and guinea pigs. The melanin content and cytotoxicity were assessed in melanocytes; in 3-dimensional models, the melanin concentration and the number of active melanocytes were determined. Results: RAL was taken up by melanocytes and mostly metabolised to retinol and retinyl esters, and to a lesser extent to RA. RAL decreased the melanin concentration of guinea pig ears and mouse tails by 54 and 74%, respectively, and decreased the number of active melanocytes by 42 and 77%, respectively. In reconstructed epidermis the melanin concentration was increased by 52%, whereas the number of active melanocytes decreased by 44%. Conclusion: RAL exerts a significant depigmenting activity with a mode of action that looks different from that of RA. Our data suggest a skin-lightening effect related to a melanolytic action (i.e. a decrease in melanin concentration, whatever the mechanism) rather than to melanocytotoxicity, besides other still unknown actions of RAL on melanocytes.

[1]  J. Saurat,et al.  The Combination of a Retinoid, a Phenolic Agent and an Antioxidant Improves Tolerance while Retaining an Optimal Depigmenting Action in Reconstructed Epidermis , 2013, Dermatology.

[2]  J. Saurat,et al.  Ebselen is a new skin depigmenting agent that inhibits melanin biosynthesis and melanosomal transfer , 2012, Experimental dermatology.

[3]  J. Saurat,et al.  A new spectrophotometric method for simple quantification of melanosomal transfer from melanocytes to keratinocytes , 2011, Experimental dermatology.

[4]  D. Schadendorf,et al.  Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT , 2011, Experimental dermatology.

[5]  Te-Sheng Chang,et al.  An Updated Review of Tyrosinase Inhibitors , 2009, International journal of molecular sciences.

[6]  C. Hertel,et al.  1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a novel tyrosinase inhibitor with strong depigmenting effects. , 2008, Chemical & pharmaceutical bulletin.

[7]  J. Saurat,et al.  Metabolism and biological activities of topical 4-oxoretinoids in mouse skin. , 2008, The Journal of investigative dermatology.

[8]  Francisco Solano,et al.  Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.

[9]  J. Saurat,et al.  Retinoids in cosmeceuticals , 2006, Dermatologic therapy.

[10]  J. Saurat,et al.  Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin , 2006, Experimental dermatology.

[11]  J. Saurat,et al.  Spectral Properties of Topical Retinoids Prevent DNA Damage and Apoptosis After Acute UV‐B Exposure in Hairless Mice ¶ , 2005 .

[12]  J. Saurat,et al.  Comparative analysis of the expression of ERBIN and Erb‐B2 in normal human skin and cutaneous carcinomas , 2005, The British journal of dermatology.

[13]  H. Uyama,et al.  Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future , 2005, Cellular and Molecular Life Sciences CMLS.

[14]  J. Saurat,et al.  The Depigmenting Effect of RALGA in C57BL/6 Mice , 2005, Dermatology.

[15]  J. Saurat,et al.  Spectral Properties of Topical Retinoids Prevent DNA Damage and Apoptosis After Acute UV-B Exposure in Hairless Mice¶ , 2005, Photochemistry and photobiology.

[16]  Patries M Herst,et al.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. , 2005, Biotechnology annual review.

[17]  J. Saurat,et al.  Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. , 2004, The Journal of investigative dermatology.

[18]  J. Saurat,et al.  Penetration and Metabolism of Topical Retinoids in ex vivo Organ-Cultured Full-Thickness Human Skin Explants , 2004, Skin Pharmacology and Physiology.

[19]  J. Saurat,et al.  The Antibacterial Activity of Topical Retinoids: The Case of Retinaldehyde , 2002, Dermatology.

[20]  V. Virador,et al.  Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. , 2001, Journal of dermatological science.

[21]  J. Saurat,et al.  Topical Delivery of Retinoids Counteracts the UVB-induced Epidermal Vitamin A Depletion in Hairless Mouse¶ , 2001, Photochemistry and photobiology.

[22]  J. Saurat,et al.  Retinol and Retinyl Ester Epidermal Pools Are Not Identically Sensitive to UVB Irradiation and Anti-Oxidant Protective Effect , 1999, Dermatology.

[23]  J. Saurat,et al.  Antibacterial Activity of Retinaldehyde against Propionibacterium acnes , 1999, Dermatology.

[24]  W. Bollag,et al.  Retinoids , 2010, Methods in Molecular Biology.

[25]  J. Saurat,et al.  New Concepts for Delivery of Topical Retinoid Activity to Human Skin , 1999 .

[26]  J. Castenmiller,et al.  Bioavailability and bioconversion of carotenoids. , 1998, Annual review of nutrition.

[27]  J. L. Napoli.  Retinoic acid biosynthesis and metabolism , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Saurat,et al.  Plasma retinoids after topical use of retinaldehyde on human skin. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[29]  J. Saurat,et al.  Topical retinaldehyde on human skin: biologic effects and tolerance. , 1994, The Journal of investigative dermatology.

[30]  A. Winder.  A stopped spectrophotometric assay for the dopa oxidase activity of tyrosinase. , 1994, Journal of biochemical and biophysical methods.

[31]  E. Aberdam,et al.  Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. , 1994, Journal of cell science.

[32]  J. Ortonne,et al.  Involvement of the melanogenic enzymes expression , 1994 .

[33]  J. Reynier,et al.  Plasma concentrations after three different doses of topical isotretinoin. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[34]  N. Kruger,et al.  The bradford method for protein quantitation. , 1988, Methods in molecular biology.